Expression of p16 gene and Rb protein in gastric carcinoma and their chinicopathological significance

World Journal of Gastroenterology

Volumn 11, Issue 15, 2005, Pages 2218-2223

  He, Xiu Sheng ^a   Rong, Ying Hui ^a   Su, Qi ^a   Luo, Qiao ^a   He, Dong Mei ^a   Li, Yan Lan ^a   Chen, Yan ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Gastric carcinoma; P16 gene

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN; PROTEIN P16INK4A; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; EXON; FEMALE; GASTROTOMY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA LESION; TUMOR SUPPRESSOR GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH TUMOR;

ADULT; AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 18744390492     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i15.2218     Document Type: Article

References (29)

1. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707
2. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440
3. Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Anticancer Res 2002; 22: 1256-1271
4. Mitani K. Molecular mechanisms in leukemogenesis. Gan To Kagaku Ryoho 2002; 29: 1107-1112
5. Sasaki S, Kitagawa Y, Sekido Y, Minna JD, Kuwano H, Yokota J, Kohno T. Molecular processes of chromosome 9p21 deletions in human cancers. Oncogene 2003; 22: 3792-3798
6. He XS, Su Q, Chen ZC, He XT, Che SY. Expression, Mutation and Deletion of p16 Gene in gastric carcinoma. Aizheng 2001; 20: 468-473
7. BorrmanR. Geschwülste des Magens und Duodenums. In Henke F. Lubarsch O. eds: Handbuch der Speziellen Pathologischen Anatomie und Histologie. Berlin Julius Springer 1926: 864-871
8. Sambrook J, Frisch EF, Maniatis T. Molecular Cloning, A Laboratory Manual 2nded, Cold Spring Harbor Laboratory Press 1989
9. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 2000; 12(35 Suppl): 111-115
10. Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J. Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res 1996; 56: 3415-3420
11. Jarrard DF, Modder J, Fadden P, Fu V, Sebree L, Heisey D, Schwarze SR, Friedl A. Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Lett 2002; 185: 191-199
12. Mobley SR, Liu TJ, Hudson JM, Clayman GL. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg 1998; 124: 88-92
13. Tsujie M, Yamamoto H, Tomita N, Sugita Y, Ohue M, Sakita I, Tamaki Y, Sekimoto M, Doki Y, Inoue M, Matsuura N, Monden T, Shiozaki H, Monden M. Expression of tumor suppressor gene p16(INK4) products in primary gastric cancer. Oncology 2000; 58: 126-136
14. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995; 55: 1351-1354
15. Frizelle SP, Grim J, Zhou J, Gupta P, Curiel DT, Geradts J, Kratzke RA. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene 1998; 16: 3087-3095
16. Nguyen TT, Nguyen CT, Gonzales FA, Nichols PW, Yu MC, Jones PA. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers. Prostate 2000; 43: 233-242
17. Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ. Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res 1995; 55: 1941-1945
18. Kawabuchi B, Moriyama S, Hironaka M, Fujii T, Koike M, Moriyama H, Nishimura Y, Mizuno S, Fukayama M. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis. Int J Cancer 1999; 84: 49-53
19. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Elevated P16 at senescence and loss of P16 at immortalization in human papillomavirus 16E6, but not E7, transformed human uroepithelial cells. Cancer Res 1996; 56: 2886-2890
20. Geradts J, Hruban RH, Schutte M, Kern SE, Maynard R. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies. Appl Immunohistochem Mol Morphol 2000; 8: 71-79
21. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 1995; 55: 505-509
22. Tam SW, Shay JW, Pagano M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor P16 INK4. Cancer Res 1994; 54: 5816-5820
23. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 1995; 55: 6200-6209
24. Giroux MA, Audrezet MP, Metges JP, Lozac'h P, Volant A, Nousbaum JB, Labat JP, Gouerou H, Ferec C, Robaszkiewicz M. Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol 2002; 14: 15-18
25. Gunther T, Schneider-Stock R, Pross M, Manger T, Malfertheiner P, Lippert H, Roessner A. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer. Pathol Res Pract 1998; 194: 809-813
26. Sakata K, Tamura G, Maesawa C, Suzuki Y, Terashima M, Satoh K, Eda Y, Suzuki A, Sekiyama S, Satodate R. Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas. Jpn J Cancer Res 1995; 86: 333-335
27. Ficorella C, Cannita K, Ricevuto E, Toniato E, Fusco C, Sinopoli NT, De Galitiis F, Di Rocco ZC, Porzio G, Frati L, Gulino A, Martinotti S, Marchetti P. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer. Oncol Rep 2003; 10: 169-173
28. Ogawa M, Maeda K, Chung YS, Onoda N, Kato Y, Nakata B, Sowa M. Correlation between expression of RB protein and prognosis of gastric cancer. Gan To Kagaku Ryoho 1996; 23 (Suppl 2): 148-150
29. Lee WA, Woo DK, Kim YI, Kim WH. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach. Pathol Res Pract 1999; 195: 747-752